Skip to main content
Log in

DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

There are a number of rheumatologic manifestations of human retroviral infections associated with human immunodeficiency virus type I (HIV-I) and the human T-cell leukemia virus type I (HTLV-I) including arthritis, Sjøgren's syndrome-like symptoms as well as other varied autoimmune phenomena. Infection with HTLV-1 may be directly involved in the etiology and/or pathogenesis of an arthritic condition similar to rheumatoid arthritis. We have been characterizing a new vaccination strategy against human retroviral infections, designated DNA inoculation. This procedure involves the intramuscular injection of DNA plasmids which express specific human retroviral antigens. This technique results in the development of humoral and cellular immune responses against these proteins. Specifically, this method has been successfully used to develop immune responses against HIV-I and HTLV-I. The availability of rat and rabbit infection models for HTLV-I, coupled with the successful development of immune responses in these animals after DNA inoculation with an HTLV-I envelope expressing plasmid, will allow the efficacy of this vaccination technique to be evaluated with protection against in vivo viral challenge as an endpoint.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cheevers WP, Knowles DPJ, Norton LK: Neutralization-resistant antigenic variants of caprine arthritisencephalitis lentivirus associated with progressive arthritis. J Infect Dis 1991;164:679–685.

    PubMed  CAS  Google Scholar 

  2. Cork LC, Narayan O: The pathogenesis of viral leukoencephalomyelitisarthritis of goats. I. Persistent viral injection with progressive pathologic changes. Lab Invest 1980;41:596–602.

    Google Scholar 

  3. Crawford TB, Adams S, Sandle RD, Gorham JR, Henson JB: The connective tissue component of the caprine arthritis-encephalitis syndrome. Am J Pathol 1980;100:443–450.

    PubMed  CAS  Google Scholar 

  4. Krieg A: Retroviruses and autoimmunity. J Autoimmun 1990;3:137–166.

    Article  PubMed  CAS  Google Scholar 

  5. Spilberg I, Meyer GJ: The arthritis of leukemia. Arthritis Rheum 1972; 15:630–635.

    Article  PubMed  CAS  Google Scholar 

  6. Taniguichi A, Takenaka Y, Noda Y, Ueno Y, Schichikawa K, Sato K, Miyasaka N, Nishioka K: Adult T cell leukemia presenting with proliferative synovitis. Arthritis Rheum 1988;31:1976–1077.

    Google Scholar 

  7. Eguchi K, Nakamura T, Mine M, Ida H, Kawakami A, Migita K, Nagasato K, Kurata A, Fukuda T, Nagataki S: HTLV-I associated arthritis: Characteristics of an HTLV-I virus infected T cell line from synovial fluid. Ann Rheum Dis 1992;51:673–677.

    PubMed  CAS  Google Scholar 

  8. Ijichi S, Matsuda T, Maruyama I, Izumihara T, Kojima K, Niimura T, Maruyama Y, Sonoda S, Yoshida A, Osame M: Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis 1990;49:718–721.

    PubMed  CAS  Google Scholar 

  9. Kitajima I, Maruyama I, Maruyama Y, Ijichi S, Eiraku N, Mimura Y, Osame M: Polyarthritis in human T lymphotropic virus type I-associated myelopathy (letter). Arthritis Rheum 1989;32:1342–1344.

    Article  PubMed  CAS  Google Scholar 

  10. Yufu Y, Nonaka S, Nobunaga M: Adult T cell leukemia-lymphoma mimicking rheumatic disease (letter). Arthritis Rheum 1987;30:599–600.

    Article  PubMed  CAS  Google Scholar 

  11. Matsumoto M, Hibiya N, Murakami A, Nishioka K: A case of HTLV-I infection complicated with multiple arthropathy and Sjogren's syndrome. Nippon Naika Gakkai Zasshi 1990;79:1589–1590.

    PubMed  CAS  Google Scholar 

  12. Kuroda Y, Fukuoka M, Endo C, Matsui M, Kurohara K, Kakigi R, Tokunaga O: Occurrence of primary biliary cirrhosis, CREST syndrome and Sjogren's syndrome in a patient with HTLV-I-associated myelopathy. J Neurol Sci 1993;116:47–51.

    PubMed  CAS  Google Scholar 

  13. Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, Kawakami A, Terada K, Shimada H, Kawabe Y, et al: Primary Sjogren's syndrome with antibodies to HTLV-I: Clinical and laboratory features. Ann Rheum Dis 1992;51:769–776.

    PubMed  CAS  Google Scholar 

  14. Itescu S, Brancato L, Buxbaum J, Solomon G, Winchester R: Sjlgren's syndrome associated with HIV infection. Arthritis Rheum 1988; 31(suppl):35.

    Google Scholar 

  15. Matsumoto Y, Muramatsu MO, Sato K: Mixed connective tissue disease and Sjogren's syndrome, accompanied by HTLV-I infection. Intern Med 1993;32:261–264.

    Article  PubMed  CAS  Google Scholar 

  16. Kanazawa H, Ijichi S, Eiraku N, Igakura T, Higuchi I, Nakagawa M, Kuriyama M, Tanaka S, Osame M: Behcet's disease and Sjogren's syndrome in a patient with HTLV-I-associated myelopathy (letter). J Neurol Sci 1993;119:121–122.

    Article  PubMed  CAS  Google Scholar 

  17. Evans BK, Gore I, Harrell LE, Arnold T, Oh SJ: HTLV-I-associated myelopathy and polymyositis in a US native. Neurology 1989;39:1572–1575.

    PubMed  CAS  Google Scholar 

  18. Morgan OS, Rodgers-Johnson P, Mora C, Char G: HTLV-I and polymyositis in Jamaica. Lancet 1989;ii:1184–1187.

    Article  Google Scholar 

  19. Nishikai M, Sato A: Human T lymphotropic virus type I and polymyositis and dermatomyositis in Japan (letter). Arthritis Rheum 1991;34:791–792.

    Article  PubMed  CAS  Google Scholar 

  20. Sowa JM: Human T lymphotropic virus I, myelopathy, polymyositis and synovitis: an expanding rheumatic spectrum (see comments). J Rheumatol 1992;19:316–318.

    PubMed  CAS  Google Scholar 

  21. Wiley CA, Nerenberg M, Gros D, Soto-Aguilar MC: HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus. N Engl J Med 1989;320:992–995.

    PubMed  CAS  Google Scholar 

  22. Yoshimura K, Mochizuki M, Araki S, Miyata N, Yamaguchi K, Tajima K, Watanabe T: Clinical and immunologic features of human T-cell lymphotropic virus type I uveitis. Am J Ophthalmol 1993;116:156–163.

    PubMed  CAS  Google Scholar 

  23. Mochizuki M, Tajima K, Watanabe T, Yamaguchi K: Human T lymphotropic virus type 1 uveitis. Br J Ophthalmol 1994;78:149–154.

    Article  PubMed  CAS  Google Scholar 

  24. Mochizuki M, Yamaguchi K, Takatsuki K, Watanabe T, Mori S, Tajima K: HTLV-I and uveitis (letter, comment). Lancet 1992;339:1110.

    Article  PubMed  CAS  Google Scholar 

  25. Mochizuki M, Watanabe T, Yamaguchi K, Tajima K, Yoshimura K, Nakashima S, Shirao M, Araki S, Miyata N, Mori S, et al: Uveitis associated with human T lymphotropic virus type I: Seroepidemiologic, clinical, and virologic studies (letter). J Infect Dis 1992;166:943–944.

    PubMed  CAS  Google Scholar 

  26. Mochizuki M, Watanabe T, Yamaguchi K, Yoshimura K, Nakashima S, Shirao M, Araki S, Takatsuki K, Mori S, Miyata N: Uveitis associated with human T-cell lymphotropic virus type I. Am J Ophthalmol 1992; 114:123–129.

    PubMed  CAS  Google Scholar 

  27. Haynes BF, Miller SE, Palker TJ, Moore JO, Dunn PH, Bolognesi DP, Metzgar RS: Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. Proc Nat Acad Sci USA 1983;80:2054–2058.

    Article  PubMed  CAS  Google Scholar 

  28. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Mitsutoshi T: HTLV-I associated myelopathy, a new clinical entity. Lancet 1986;i:1031–1032.

    Article  Google Scholar 

  29. Kaye BR: Rheumatologic manifestations of infection with human immunodeficiency virus (HIV). Ann Intern Med 1989;111:158–167.

    PubMed  CAS  Google Scholar 

  30. Itescu S: Diffuse infiltrative lymphocytosis syndrome in children and adults infected with HIV-1: A model of rheumatic illness caused by acquired viral infection. Am J Reprod Immunol 1992;28:247–250.

    PubMed  CAS  Google Scholar 

  31. Couderc LJ, D'Agay MF, Dannon F, Harzic M, Brocheriou C, Clauvel JP: Sicca complex and infections with human immunodeficiency virus. Arch Intern Med 1987;147:898–901.

    Article  PubMed  CAS  Google Scholar 

  32. Walker CM, Moody DJ, Stites DP, Levy JA: CD8 lymphocytes can control HIV infection in vitro by suppressing viral replication. Science 1986;234:1563–1566.

    Article  PubMed  CAS  Google Scholar 

  33. Tsubota H, Lord CI, Watkins DI, Morimoto C, Letvin NL: A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J Exp Med 1989;169:1421–1434.

    Article  PubMed  CAS  Google Scholar 

  34. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup R, Ho D: Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261:1179–1181.

    Article  PubMed  CAS  Google Scholar 

  35. Connor R, Ho D: Transmission and pathogenesis of human immunodeficiency virus type I. AIDS Res Hum Retroviruses 1994;10:321–323.

    PubMed  CAS  Google Scholar 

  36. Epstein L, Kuiken C, Blumberg B, Hartman S, Sharer L, Clement M, Goudsmit J: HIV-I V3 domain variation in brain and spleen of children with AIDS: Tissue-specific evolution within host-determined quasispecies. Virology 1991;180:583–590.

    Article  PubMed  CAS  Google Scholar 

  37. Keys B, Karis J, Fadeel B, Valentin A, Norkrans G, Hagberg L, Chiodi F: V3 sequences of paired HIV-I isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology 1993;196:475–483.

    Article  PubMed  CAS  Google Scholar 

  38. Weber JN, Clapham PR, Weiss RA, Parker D, Roberts C, Duncan J, Weller I, Carne C, Teddler RS, Pinching AJ, Chiengsong-Popov P: Human immunodeficiency virus infection in two cohorts of homosexual men: neutralizing sera and association of anti-gag antibody with prognosis. Lancet 1987;i:119–122.

    Article  Google Scholar 

  39. Sei Y, Tsang PH, Chu FN, Wallace I, Roboz JP, Sarin PS, Bekesi JG: Inverse relationship between HIV-I p24 antigenemia, anti-p24 antibody and neutralizing antibody response in all stages of HIV-I infection. Immunol Lett 1989;20:223–230.

    Article  PubMed  CAS  Google Scholar 

  40. Lange JMA, Paul DA, Huisman HG, De Wolf F, van den Berg H, Coutinho RA, Danner SA, van der Noorda J, Goudsmit J: Persistent HIV antigenemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J 1986; 293:1459–1462.

    Article  CAS  Google Scholar 

  41. Lange JMA, de Wolf F, Krone WJA, Danner SA, Coutinho RA, Goudsmit J: Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline. AIDS 1987;1:155–159.

    PubMed  CAS  Google Scholar 

  42. Jiang JD, Chu FN, Naylor PH, Kirkley JE, Mandell J, Wallace JI, Sarin PS, Goldstein AL, Holland JF, Bekesi JG: Specific antibody responses to synthetic peptides of HIV-I p17 correlate with different stages of HIV-I infection. J Acquir Immune Defic Syndr 1992;5:382–390.

    PubMed  CAS  Google Scholar 

  43. Forster SM, Osborne LM, Cheignsong-Popov R, Kenny C, Burnell R, Jeffries DJ, Pinching AJ, Harris JRW, Weber JN: Decline of anti-p24 antibody precedes antigenaemia as a correlate of prognosis in HIV-I infection. AIDS 1987;1:235–240.

    PubMed  CAS  Google Scholar 

  44. Mackewicz CE, Ortega HW, Levy JA: CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 1991;87:1462–1466.

    Article  PubMed  CAS  Google Scholar 

  45. Phillips AN, Lee CA, Elford J, Janossy G, Timms A, Bofill M, Kernoff PBA: Serial lymphocyte counts and development of AIDS. Lancet 1991;337:389–392.

    Article  PubMed  CAS  Google Scholar 

  46. de Wolf FJ, Lange MA, Houwling TM: Numbers of CD4+ cells and the levels of core antigens and of antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis 1988;158:615–622.

    PubMed  Google Scholar 

  47. Fahey JL, Taylor JMG, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type I. N Engl J Med 1990;322:166–172.

    PubMed  CAS  Google Scholar 

  48. Kopelman RH, Zolla-Pazner S: Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 1988; 84:82–88.

    Article  PubMed  CAS  Google Scholar 

  49. Stricker RB, Abrams DI, Corash L, Shuman MA: Target platelet antigen in homosexual men with immune thrombocytopenia. N Engl J Med 1985;313:1375–1380.

    PubMed  CAS  Google Scholar 

  50. Savona S, Nardi MA, Lennette ET, Karpatkin S: Thrombocytopenic purpura in narcotic addicts. Ann Intern Med 1985;102:737–741.

    PubMed  CAS  Google Scholar 

  51. Rubinstein A, Small CB, Bernstein LJ: Autoantibodies to T cell in adult and pediatric AIDS. Ann NY Acad Sci 1985;437:508–512.

    Article  Google Scholar 

  52. Cummingham-Rundles S, Michelis MA, Masur H: Serum suppression of lymphocyte activation in vitro in acquired immunodeficiency disease. J Clin Immunol 1983;3:156–165.

    Article  Google Scholar 

  53. Murphy MF, Metcalfe P, Waters AH: Immune neutropenia in homosexual men. Lancet 1985;i:217–218.

    Article  Google Scholar 

  54. Van der Lelie J, Lange JM, Goudsmit J: Idiopathic neutropenia in homosexual men. Lancet 1985;i:936–937.

    Google Scholar 

  55. Canoso RT, Zon LI, Groopman JE: anticardiolipin antibodies associated with HTLV-III infection. Br J Haematol 1987;65:495–498.

    Article  PubMed  CAS  Google Scholar 

  56. Bloom EJ, Abrams DI, Rodgers G: Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA 1986;256:491–493.

    Article  PubMed  CAS  Google Scholar 

  57. McDougal JS, Hubbard M, Nicholson JK, et al: Immune complexes in the acquired immunodeficiency syndrome (AIDS): Relationship to disease manifestation, risk group, and immunologic defect. J Clin Immunol 1985;5:130–138.

    Article  PubMed  CAS  Google Scholar 

  58. Yu JR, Lennette ET, Karpatkin S: Anti-F(ab′)2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome. J Clin Invest 1986;77:1756–1761.

    Article  PubMed  CAS  Google Scholar 

  59. Moss B: Use of vaccinia virus vectors for development of AIDS vaccines. AIDS 1988;2(suppl):103–105.

    Article  Google Scholar 

  60. Moss B, Fuerst TR, Flexner C, Hugin A: Roles of vaccinia virus in the development of new vaccines. Vaccine 1988;6:161–163.

    Article  PubMed  CAS  Google Scholar 

  61. Acsadi G, Dickson G, Love DR, Jani A, Walsh FS, Gurushinghe A, Wolff JA, Davies KE: Human dystrophin expression in mdx mice after intrasmucular injection of DNA constructs. Nature 1991;352:815–818.

    Article  PubMed  CAS  Google Scholar 

  62. Ulmer JB, Donnelly J, Parker SE, Rhodes GH, Felgner PL, Dwarki VL, Gromkowski SH, Deck R, DeVitt CM, Friedman A, Hawe LA, Leander KR, Marinez D, Perry H, Shiver JW, Montgomery D, Liu MA: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259:1745–1749.

    Article  PubMed  CAS  Google Scholar 

  63. Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, Weiner DB: Gene inoculation generates immune responses against human immunodeficiency virus type I. Proc Natl Acad Sci USA 1993;90: 4156–4160.

    Article  PubMed  CAS  Google Scholar 

  64. Wang B, Boyer J, Srikantan V, Coney L, Carrano R, Phan C, Merva M, Dang K, Agadjanyan M, Gilbert L, Ugen K, Williams VW, Weiner DB: DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol 1993;12:799–805.

    PubMed  CAS  Google Scholar 

  65. Wang B, Ugen EK, Srikantan V, Agaduanyan M, Dang K, Sato AI, Refaeli Y, Boyer J, Williams WV, Weiner DB: Genetic Immunization: A Novel Method for Vaccine Development against HIV. Vaccines 93 New York, Cold Spring Harbor Laboratory Press, pp 1993, 143–150.

    Google Scholar 

  66. Wang B, Merva M, Dang K, Ugen K, Boyer J, Williams VW, Weiner DB: DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen expressing cells. AIDS Res Hum Retroviruses 1994;10:S35-S41.

    PubMed  CAS  Google Scholar 

  67. Hui KM, Sim T, Foo TT, Oei A: Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene. J Immunol 1989;143:3835–3843.

    PubMed  CAS  Google Scholar 

  68. Bernards R, Destree A, McKenzie S, Gordon E, Weinber RA, Peicali D: Effective tumor immunotherapy directed against an oncogene-encoded product using vaccinia vector. Proc Natl Acad Sci USA 1987;84:6854–6858.

    Article  PubMed  CAS  Google Scholar 

  69. Williams WV, Boyer JD, Merva M, LiVolsi V, Wilson D, Wang B, Weiner DB: Genetic infection induces protective in vivo immune responses. DNA Cell Biol 1993;12:675–683.

    PubMed  CAS  Google Scholar 

  70. Agadjanyan MG, Wang B, Ugen KE, Merva M, Williams WV, Weiner DB: Immune responses in rabbits after genetic inoculation with an HTLV-I envelope DNA construct. Vaccines 1994;94:47–54.

    Google Scholar 

  71. Akagi T, Takeda I, Oka T, Ohtsuki Y, Yano S, Miyoshi I: Experimental infection of rabbits with human T-cell leukemia virus type I. Jpn J Cancer Res 1985;76:86–94.

    PubMed  CAS  Google Scholar 

  72. Nagy K, Clapham P, Cheingsong-Popov R, Weiss R: Human T-cell leukemia virus type I: Induction of syncytia formation and inhibition by patients' sera. Int J Cancer 1983; 32:321–328.

    Article  PubMed  CAS  Google Scholar 

  73. Hoshino H, Shimoyama M, Miwa M, Sugimura T: Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytia induction assay. Proc Natl Acad Sci USA 1983; 80:7337–7341.

    Article  PubMed  CAS  Google Scholar 

  74. Nakamura H, Hayami M, Ohta Y, Ishikawa K, Tsuimoto H, Kiyokawa T, Yoshida M, Sasagawa A, Honjo S: Protection of cynomologus monkeys against infection by human T-cell leukemia virus type-I by immunization with viral env gene products produced inEscherichia coli. Int J Cancer 1987;40:403–407.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ugen, K.E., Wang, B., Ayyavoo, V. et al. DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations. Immunol Res 13, 154–162 (1994). https://doi.org/10.1007/BF02918276

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02918276

Key Words

Navigation